Brian Pepin is CEO of Rune Labs, a precision neurology company supporting care delivery and therapy development for Parkinson’s patients through the utilization of StrivePD, an AI-powered disease management tool.
The bi-partisan passage during an election year of the End Parkinson’s Act shows that addressing a healthcare crisis, especially in our senior population, may be one of the few remaining issues that transcend party lines.
New technologies for quantifying behavioral information and tracking neurological patterns have the potential to change treatment—but we must connect the data.
In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play.